Carmen De Lucas Collantes

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Journal: Kidney medicine
Published: February 09, 2026

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Journal: European journal of endocrinology
Published: January 20, 2026

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Journal: European journal of endocrinology
Published: January 20, 2026

Cardiac arrest in a previously healthy infant caused by secondary pseudohypoaldosteronism: Case report and literature review.

Cardiac arrest in a previously healthy infant caused by secondary pseudohypoaldosteronism: Case report and literature review.

Journal: Medicina intensiva
Published: August 13, 2025

DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.

DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.

Journal: Science advances
Published: December 06, 2023

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.

Journal: Orphanet journal of rare diseases
Published: December 21, 2022

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data.

Journal: Orphanet journal of rare diseases
Published: December 21, 2022

Fanconi Syndrome Secondary to Sodium Valproate Therapy: Experience and Literature Review.

Fanconi Syndrome Secondary to Sodium Valproate Therapy: Experience and Literature Review.

Journal: Pediatric neurology
Published: October 13, 2021

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description.

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description.

Journal: Therapeutic advances in chronic disease
Published: October 08, 2021

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description.

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description.

Journal: Therapeutic advances in chronic disease
Published: October 08, 2021

UMOD-related autosomal dominant tubulointerstitial kidney disease: an unfavourable novel mutation.

UMOD-related autosomal dominant tubulointerstitial kidney disease: an unfavourable novel mutation.

Journal: Nefrologia
Published: March 28, 2021

UMOD-related autosomal dominant tubulointerstitial kidney disease: An unfavourable novel mutation.

UMOD-related autosomal dominant tubulointerstitial kidney disease: An unfavourable novel mutation.

Journal: Nefrologia
Published: March 28, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026